Considerations related to the use of recombinant human growth hormone in children

Jr Berlin; D. G. McCarver-May; D. A. Notterman; R. M. Ward; D. N. Weismann; G. S. Wilson; J. T. Wilson; E. B. Weller; D. R. Bennett; J. Mulinare; I. A. Hoskins; P. Kaufman; C. Krough; M. J. Rieder; G. Troendler; S. J. Yaffe; C. J. Cote; S. J. Szefler; J. L. Blumer

doi:10.1542/peds.99.1.122

Considerations related to the use of recombinant human growth hormone in children

Jr Berlin, D. G. McCarver-May, D. A. Notterman, R. M. Ward, D. N. Weismann, G. S. Wilson, J. T. Wilson, E. B. Weller, D. R. Bennett, J. Mulinare, I. A. Hoskins, P. Kaufman, C. Krough, M. J. Rieder, G. Troendler, S. J. Yaffe, C. J. Cote, S. J. Szefler, J. L. Blumer

Molecular Biology

Research output: Contribution to journal › Review article › peer-review

57 Scopus citations

Abstract

Since 1985 molecular biology techniques have made possible the synthetic synthesis of pure human growth hormone in potentially unlimited amounts. With this increased availability its use in patients other than children with growth hormone deficiency has been associated with clinical ethical questions. This statement presents an analysis of the current status of the use of human growth hormone in children.

Original language	English (US)
Pages (from-to)	122-129
Number of pages	8
Journal	Pediatrics
Volume	99
Issue number	1
DOIs	https://doi.org/10.1542/peds.99.1.122
State	Published - 1997

All Science Journal Classification (ASJC) codes

Pediatrics, Perinatology, and Child Health

Access to Document

10.1542/peds.99.1.122

Cite this

Berlin, J., McCarver-May, D. G., Notterman, D. A., Ward, R. M., Weismann, D. N., Wilson, G. S., Wilson, J. T., Weller, E. B., Bennett, D. R., Mulinare, J., Hoskins, I. A., Kaufman, P., Krough, C., Rieder, M. J., Troendler, G., Yaffe, S. J., Cote, C. J., Szefler, S. J., & Blumer, J. L. (1997). Considerations related to the use of recombinant human growth hormone in children. Pediatrics, 99(1), 122-129. https://doi.org/10.1542/peds.99.1.122

@article{7fc0a8893143443fb63166dda5ae2926,

title = "Considerations related to the use of recombinant human growth hormone in children",

abstract = "Since 1985 molecular biology techniques have made possible the synthetic synthesis of pure human growth hormone in potentially unlimited amounts. With this increased availability its use in patients other than children with growth hormone deficiency has been associated with clinical ethical questions. This statement presents an analysis of the current status of the use of human growth hormone in children.",

author = "Jr Berlin and McCarver-May, {D. G.} and Notterman, {D. A.} and Ward, {R. M.} and Weismann, {D. N.} and Wilson, {G. S.} and Wilson, {J. T.} and Weller, {E. B.} and Bennett, {D. R.} and J. Mulinare and Hoskins, {I. A.} and P. Kaufman and C. Krough and Rieder, {M. J.} and G. Troendler and Yaffe, {S. J.} and Cote, {C. J.} and Szefler, {S. J.} and Blumer, {J. L.}",

year = "1997",

doi = "10.1542/peds.99.1.122",

language = "English (US)",

volume = "99",

pages = "122--129",

journal = "Pediatrics",

issn = "0031-4005",

publisher = "American Academy of Pediatrics",

number = "1",

}

Berlin, J, McCarver-May, DG, Notterman, DA, Ward, RM, Weismann, DN, Wilson, GS, Wilson, JT, Weller, EB, Bennett, DR, Mulinare, J, Hoskins, IA, Kaufman, P, Krough, C, Rieder, MJ, Troendler, G, Yaffe, SJ, Cote, CJ, Szefler, SJ & Blumer, JL 1997, 'Considerations related to the use of recombinant human growth hormone in children', Pediatrics, vol. 99, no. 1, pp. 122-129. https://doi.org/10.1542/peds.99.1.122

TY - JOUR

T1 - Considerations related to the use of recombinant human growth hormone in children

AU - Berlin, Jr

AU - McCarver-May, D. G.

AU - Notterman, D. A.

AU - Ward, R. M.

AU - Weismann, D. N.

AU - Wilson, G. S.

AU - Wilson, J. T.

AU - Weller, E. B.

AU - Bennett, D. R.

AU - Mulinare, J.

AU - Hoskins, I. A.

AU - Kaufman, P.

AU - Krough, C.

AU - Rieder, M. J.

AU - Troendler, G.

AU - Yaffe, S. J.

AU - Cote, C. J.

AU - Szefler, S. J.

AU - Blumer, J. L.

PY - 1997

Y1 - 1997

N2 - Since 1985 molecular biology techniques have made possible the synthetic synthesis of pure human growth hormone in potentially unlimited amounts. With this increased availability its use in patients other than children with growth hormone deficiency has been associated with clinical ethical questions. This statement presents an analysis of the current status of the use of human growth hormone in children.

AB - Since 1985 molecular biology techniques have made possible the synthetic synthesis of pure human growth hormone in potentially unlimited amounts. With this increased availability its use in patients other than children with growth hormone deficiency has been associated with clinical ethical questions. This statement presents an analysis of the current status of the use of human growth hormone in children.

UR - http://www.scopus.com/inward/record.url?scp=0031004187&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031004187&partnerID=8YFLogxK

U2 - 10.1542/peds.99.1.122

DO - 10.1542/peds.99.1.122

M3 - Review article

C2 - 8989348

AN - SCOPUS:0031004187

SN - 0031-4005

VL - 99

SP - 122

EP - 129

JO - Pediatrics

JF - Pediatrics

IS - 1

ER -

Considerations related to the use of recombinant human growth hormone in children

Abstract

All Science Journal Classification (ASJC) codes

Access to Document

Other files and links

Fingerprint

Cite this